pRESET for Occlusive Stroke Treatment
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 340 participants.
Also called NCT03994822
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 340 participants
- Sponsor
- phenox Inc.
- Registry
-
NCT03994822
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States, Germany
- Registry status
- Completed
Technical summary
Registry record NCT03994822. Randomized; single masking; primary purpose treatment. Start 2019-10-04 (actual); primary completion 2022-05-12 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- pRESET for Occlusive Stroke Treatment
- Acronym
- PROST
- Condition
- Brain Diseases
- Condition
- Cardiovascular Diseases
- Condition
- Central Nervous System Diseases
- Condition
- Cerebrovascular Disorders
- Condition
- Ischemia
- Condition
- Nervous System Diseases
- Condition
- Pathologic Processes
- Condition
- Stroke, Ischemic
- Condition
- Stroke, Acute
- Condition
- Vascular Diseases
- Intervention (Device)
- Mechanical Thrombectomy using the pRESET Thrombectomy device
- Intervention (Device)
- Mechanical Thrombectomy using the Solitaire Revascularization Device
- Lead sponsor
- phenox Inc.
Record details
- Record id
cardio:ct-nct03994822- Content hash
4b092047b83a5b8e089236c4d3724d78930cb49420f5948f2f09cb1f649ad9e0